MYCOPHENOLATE for Haematological malignancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 49 adverse event reports in the FDA FAERS database where MYCOPHENOLATE was used for Haematological malignancy.

Most Reported Side Effects for MYCOPHENOLATE

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	622	8.0%	75	313
Death	615	7.9%	614	37
Off label use	572	7.3%	32	169
Drug ineffective	380	4.9%	34	116
Pyrexia	374	4.8%	44	270
Blood creatinine increased	305	3.9%	12	204
Malaise	288	3.7%	21	85
Hypertension	280	3.6%	16	113
Haemoglobin decreased	272	3.5%	3	163
Product use in unapproved indication	272	3.5%	16	75
Acute kidney injury	267	3.4%	37	202
Nausea	260	3.3%	45	115
Urinary tract infection	260	3.3%	25	162
Pneumonia	246	3.2%	58	176
Leukopenia	231	3.0%	17	120